Which Indian city for pharma R&D?

Pune for chemistry, formulation, clinical data and pharmacovigilance; Hyderabad for vaccines, biostats, bulk-drug R&D and CMC; Mumbai for regulatory and commercial ops; Bangalore for biotech, bioinformatics, AI-for-drug-discovery and RWE analytics.

Do India pharma GCCs meet FDA and EMA standards?

Yes. India has more US-FDA approved facilities than any country outside the US. Indian pharma GCCs are routinely audited by FDA, EMA, MHRA and PMDA without findings. We operate under 21 CFR Part 11, EU Annex 11, ICH-GCP / GLP / GMP and GAMP 5.

What pharma capabilities can a India GCC own end-to-end?

Clinical operations, biostatistics, SAS programming, pharmacovigilance (ICSR + aggregate), regulatory affairs (eCTD), medical writing, medical affairs, HEOR, RWE, commercial analytics, R&D chemistry, formulation, bioinformatics and AI-led drug discovery.

How fast can a Pharma GCC be operational?

120 to 180 days for a 100 to 300 FTE captive under our Managed GCC or BOT model. Validated Veeva and Argus environments, CDSCO registrations, GxP-aware facility and recruited PV / RA / biostats leadership inside six months.

Vertical Pillar

Hyderabad

Mumbai

Pune

Bangalore

Pharma & Life Sciences GCC Setup in India

Mumbai + Pune + Hyderabad-via-Pune, pharma R&D, regulatory and commercial ops at scale.

Clinical operations, regulatory affairs, pharmacovigilance, medical writing, RWE analytics and commercial ops for global pharma, biotech and med-device companies.

Market size

USD 7 Bn India pharma GCC sector by 2027

Talent depth

120,000+ life-sciences GCC professionals; PhD bench at IISER, NCL, IIT Bombay

Cost range

USD 30 to 55K per FTE

Plan your Pharma GCC +91 9108246387